Moderna will be reducing the size of expected second-quarter deliveries of its Covid-19 vaccine to a number of countries, including Canada and the UK, due to supply chain issues, the company said in a statement sent to CNN on Friday.
“Taking into account the current supply, demand, and distribution landscape, Moderna will be making adjustments to expected Q2 delivery quantities in a number of countries including Canada and the U.K.,” the company said.
“The trajectory of vaccine manufacturing ramp-up is not linear, and despite best efforts, there is a shortfall in previously estimated doses from the European supply chain," the statement added.
The company did not say how much this reduction would be or how quickly the dose shortfall could be fixed. Moderna said it’s working with drug substance manufacturing partner Lonza to deliver a sustained supply in the “shortest possible timeframe” and is in “close contact with all governments.”